SOURCE: Tech Council of Maryland

Tech Council of Maryland

February 22, 2010 14:39 ET

Tech Council of Maryland to Host BioBreakfast Focusing on Commercial Implications of Personalized Medicine

Breakfast Series Features Dr. Janet Woodcock, Director of the FDA's Center for Drug Evaluation and Research

ROCKVILLE, MD--(Marketwire - February 22, 2010) -


WHO:   The Tech Council of Maryland (TCM)

WHAT:  BioBreakfast Series: Commercial Implications
       of Personalized Medicine

WHERE: Center for Advanced Research in Biotechnology (CARB)
       9600 Gudelsky Drive
       Auditorium - Room A-107
       Rockville, MD 20850

WHEN:  February 26, 2010
       7:30 a.m. - 10:30 a.m.
NOTE:  Registration and networking from 7:30 a.m. - 8:15 a.m.,
       program begins at 8:30 a.m.

WHY:   The wealth of information made possible by advancements in genomic
       science is paving the way for the development of "targeted"
       diagnostic tests and therapeutics based on an individual's genetic
       profile. This personalized medicine approach holds the potential to
       revolutionize healthcare by selecting the "right treatment for the
       right person at the right time." What are the commercial
       opportunities and regulatory challenges posed by the personalized
       medicine revolution? And how will this revolution shape the
       strategies of companies engaged in the development of drugs and
       diagnostics?

       This BioBreakfast program features a panel of preeminent experts
       who will share some of the exciting commercial breakthroughs as
       well as the regulatory and legislative developments expected to
       affect the advancement of personalized medicine in the near-term.

       Panelists:
       -- Dr. Stephen Little, Vice President, Personalized Healthcare
          at QIAGEN
       -- Eric K. Rowinsky, M.D., Chief Medical Officer
          at Champions Biotechnology
       -- Christopher Wasden, Managing Director of Strategy and Innovation
          at Pricewaterhouse Coopers
       -- Janet Woodcock, M.D., Director of the Center for Drug Evaluation
          and Research at the U.S. Food and Drug Administration

       Moderator:
       Karen Lovitch, Member, Mintz, Levin, Cohn, Ferris, Glovsky
       and Popeo, P.C.

To register or for more information, please visit the Tech Council of Maryland's Web site https://techcouncilmd.com/events/detail.php?list=Events&laction=detail.php&evt_id=228.

ABOUT THE TECH COUNCIL OF MARYLAND

The Tech Council of Maryland (TCM) is the largest technology trade group serving the advanced technology and biotechnology communities of Maryland. TCM's mission is to advocate for the interests of the technology community, further the role of technology in the Maryland economy, and nurture an environment where technology companies can collaborate, grow and succeed. For more information, visit www.techcouncilmd.com.

MdBio, a Division of TCM, seeks to unify, empower and advance Maryland's bioscience industry providing comprehensive support services to its members and the broader bioscience community.

Contact Information

  • Media Contact:
    Brad Wills
    Wills & Associates Public Relations
    Tel. 240.752.7171
    Email Contact